Tejeda, M., Gaal, D., Csuka, O., Ullrich, A., Schwab, R., Pap, A., et al. (2003). The antitumor effect of the somatostatin analogue TT-232 depends on the treatment regimen. Cancer Detection and Prevention, 27(2), 155-162.